SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

SPY is experiencing a notable overnight rally driven by renewed ceasefire hopes and de-escalation signals in the Middle East, leading to a sharp drop in oil prices. While bulls are celebrating the recovery of key technical levels, the community remains divided, with some traders warning of a potential trap before a heavy week of earnings and central bank decisions.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is trending as investors react to new federal executive orders aimed at accelerating U.S. quantum technology leadership and secure data migration. The community is actively debating the stock's long-term potential versus concerns over high cash burn rates, recent insider selling, and the reliability of government-linked catalysts.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is trending as investors react to a significant jump in liquefaction fees and strong Q2 earnings guidance amid persistent global supply disruptions caused by conflict in the Middle East. The community is actively discussing the stock's potential for significant growth as it expands its LNG export capacity, while also debating the impact of geopolitical volatility and market manipulation on its current valuation.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is facing significant downward pressure as market participants debate the long-term viability of its massive AI infrastructure debt and its heavy concentration of contracts with OpenAI. While some investors are viewing the current price levels as a deep-value buying opportunity fueled by major enterprise and government partnerships, community sentiment remains highly divided between those betting on an epic turnaround and others warning of ongoing liquidity risks.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is facing a pivotal week as investors await the upcoming FDA advisory committee meeting to review deramiocel for Duchenne muscular dystrophy. The community is heavily focused on whether the panel will recommend a broad label covering both cardiac and skeletal muscle function, with intense discussion surrounding the recent physician and patient advocacy efforts pushing for approval of this treatment.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corporation is experiencing significant volatility driven by concerns over May commercial sales data and speculative fears regarding competitive trial readouts from AstraZeneca. While the community remains divided, many long-term investors are pointing to the upcoming J-code activation and EMA regulatory decisions as key catalysts, viewing the current price action as a buying opportunity.

ExxonMobil is an international oil and gas company, providing energy that helps underpin growing economies and improve living standards around the world. It uses innovation and technology to deliver energy to a growing world. The company explores for, produces, and sells crude oil, natural gas and petroleum products.

ExxonMobil Holdings Corp.

Exxon Mobil Corp

Exxon Mobil is currently a major focus for investors as the energy sector reacts to shifting geopolitical tensions in the Middle East and ongoing uncertainty regarding oil supply chains. The community is actively debating the impact of these developments on upstream earnings, share buyback programs, and the broader relative strength of energy stocks compared to the tech-heavy market.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

TSLA is seeing heavy volatility as investors debate the impact of major capital expenditures on AI, robotics, and autonomy projects following a recent earnings miss. The community remains deeply polarized, with active discussion revolving around whether this represents a temporary pullback for long-term growth or a structural decline due to intense competition and shifting market narratives.

Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. Its lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis. The company was founded by Paul A. Wagner on May 3, 2017 and is headquartered in Dallas, TX.

Forte Biosciences Inc

Forte Biosciences is trending as investors react to a significant oversubscribed private placement, which has triggered extreme volatility and intense community speculation regarding potential dilution versus long-term growth. Traders are actively debating whether this movement represents a sustainable momentum breakout or a typical biotech pump-and-dump setup.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is currently drawing significant investor attention due to positive legal developments in Thailand and a high-profile presence at industry events, which are fueling community hopes for a potential rebound and eventual major exchange relisting. Despite broader market volatility in Chinese equities and ongoing debate regarding margins versus growth, long-term investors remain focused on the company's aggressive store expansion and the impact of the newly authorized share buyback program.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

KraneShares Trust - KraneShares 2x Long PDD Daily ETF

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$5.30
Prev Close	$5.40
Open	$5.35
Dividend Yield	N/A
50-Day Moving Average	$5.81
Beta	N/A
Avg. Volume	361,161.30
PE Ratio	N/A

52-Week High	$29.15
52-Week Low	$4.10
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

KPDDKraneShares 2x-leveraged Long ETF

Latest KPDD News